This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Other. Active years: 2009-2010.
Company Filing History:
2 out of 834,411 Years Active: 2009-2010
Title: Katya McLane: Innovator in Anti-TNFα Antibodies
Introduction
Katya McLane is a prominent inventor based in Vista, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of anti-TNFα antibodies. With a total of 2 patents, her work focuses on innovative methods to treat TNFα-related diseases.
Latest Patents
Katya's latest patents include groundbreaking research on anti-TNFα antibodies and methods of use. These patents disclose novel TNFα antibody polypeptides and nucleic acids. Additionally, they outline methods for utilizing these polypeptides to effectively treat TNFα-related diseases.
Career Highlights
Throughout her career, Katya has worked with notable companies, including Janssen Biotech, Inc. Her expertise in the field has led to advancements that have the potential to improve patient outcomes in various medical conditions.
Collaborations
Katya has collaborated with esteemed colleagues such as Glen A Evans and Gopalan Raghunathan. These partnerships have fostered an environment of innovation and have contributed to her success as an inventor.
Conclusion
Katya McLane's contributions to the field of biotechnology, particularly in anti-TNFα antibodies, highlight her role as a leading inventor. Her patents and collaborations reflect her commitment to advancing medical science and improving treatment options for patients.